353 related articles for article (PubMed ID: 28800639)
1. Mitochondrial impairment and melatonin protection in parkinsonian mice do not depend of inducible or neuronal nitric oxide synthases.
López A; Ortiz F; Doerrier C; Venegas C; Fernández-Ortiz M; Aranda P; Díaz-Casado ME; Fernández-Gil B; Barriocanal-Casado E; Escames G; López LC; Acuña-Castroviejo D
PLoS One; 2017; 12(8):e0183090. PubMed ID: 28800639
[TBL] [Abstract][Full Text] [Related]
2. Melatonin and its brain metabolite N(1)-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice.
Tapias V; Escames G; López LC; López A; Camacho E; Carrión MD; Entrena A; Gallo MA; Espinosa A; Acuña-Castroviejo D
J Neurosci Res; 2009 Oct; 87(13):3002-10. PubMed ID: 19437546
[TBL] [Abstract][Full Text] [Related]
3. The beneficial effects of melatonin against heart mitochondrial impairment during sepsis: inhibition of iNOS and preservation of nNOS.
Ortiz F; García JA; Acuña-Castroviejo D; Doerrier C; López A; Venegas C; Volt H; Luna-Sánchez M; López LC; Escames G
J Pineal Res; 2014 Jan; 56(1):71-81. PubMed ID: 24117944
[TBL] [Abstract][Full Text] [Related]
4. Endurance exercise training protects against the upregulation of nitric oxide in the striatum of MPTP/probenecid mouse model of Parkinson's disease.
Al-Jarrah M; Obaidat H; Bataineh Z; Walton L; Al-Khateeb A
NeuroRehabilitation; 2013; 32(1):141-7. PubMed ID: 23422467
[TBL] [Abstract][Full Text] [Related]
5. Combining nitric oxide release with anti-inflammatory activity preserves nigrostriatal dopaminergic innervation and prevents motor impairment in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease.
L'Episcopo F; Tirolo C; Caniglia S; Testa N; Serra PA; Impagnatiello F; Morale MC; Marchetti B
J Neuroinflammation; 2010 Nov; 7():83. PubMed ID: 21092260
[TBL] [Abstract][Full Text] [Related]
6. Contribution of inducible and neuronal nitric oxide synthases to mitochondrial damage and melatonin rescue in LPS-treated mice.
García JA; Ortiz F; Miana J; Doerrier C; Fernández-Ortiz M; Rusanova I; Escames G; García JJ; Acuña-Castroviejo D
J Physiol Biochem; 2017 May; 73(2):235-244. PubMed ID: 28110436
[TBL] [Abstract][Full Text] [Related]
7. Protective effects of synthetic kynurenines on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice.
Acuña-Castroviejo D; Tapias V; López LC; Doerrier C; Camacho E; Carrión MD; Mora F; Espinosa A; Escames G
Brain Res Bull; 2011 May; 85(3-4):133-40. PubMed ID: 21419832
[TBL] [Abstract][Full Text] [Related]
8. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease.
Wu DC; Jackson-Lewis V; Vila M; Tieu K; Teismann P; Vadseth C; Choi DK; Ischiropoulos H; Przedborski S
J Neurosci; 2002 Mar; 22(5):1763-71. PubMed ID: 11880505
[TBL] [Abstract][Full Text] [Related]
9. [Possible mechanisms of the protective effect of ginsenoside Rg1 on apoptosis in substantia nigra neurons].
Chen Y; Chen XC
Yao Xue Xue Bao; 2002 Apr; 37(4):249-52. PubMed ID: 12579817
[TBL] [Abstract][Full Text] [Related]
10. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity.
Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM
Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444
[TBL] [Abstract][Full Text] [Related]
11. Role of nitric oxide synthase against MPTP neurotoxicity in mice.
Kurosaki R; Muramatsu Y; Michimata M; Matsubara M; Kato H; Imai Y; Itoyama Y; Araki T
Neurol Res; 2002 Oct; 24(7):655-62. PubMed ID: 12392201
[TBL] [Abstract][Full Text] [Related]
12. Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons.
Chen XC; Chen Y; Zhu YG; Fang F; Chen LM
Acta Pharmacol Sin; 2002 Sep; 23(9):829-34. PubMed ID: 12230953
[TBL] [Abstract][Full Text] [Related]
13. Protective effects of neuronal nitric oxide synthase inhibitor in mouse brain against MPTP neurotoxicity: an immunohistological study.
Watanabe H; Muramatsu Y; Kurosaki R; Michimata M; Matsubara M; Imai Y; Araki T
Eur Neuropsychopharmacol; 2004 Mar; 14(2):93-104. PubMed ID: 15013024
[TBL] [Abstract][Full Text] [Related]
14. Neuronal or inducible nitric oxide synthase (NOS) expression level is not involved in the different susceptibility to nigro-striatal dopaminergic neurotoxicity induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) between C57BL/6 and BALB/c mice.
Ito T; Uchida K; Nakayama H
Exp Toxicol Pathol; 2013 Jan; 65(1-2):121-5. PubMed ID: 21788124
[TBL] [Abstract][Full Text] [Related]
15. [Effect of phosphorylated-ERK1/2 on inducible nitric oxide synthase expression in the substantia nigra of mice with MPTP-induced Parkinson disease].
Shi C; Zhang YX; Zhang ZF
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Jan; 29(1):60-3. PubMed ID: 19218114
[TBL] [Abstract][Full Text] [Related]
16. Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease.
Schwenkgrub J; Joniec-Maciejak I; Sznejder-Pachołek A; Wawer A; Ciesielska A; Bankiewicz K; Członkowska A; Członkowski A
Pharmacol Rep; 2013; 65(1):44-9. PubMed ID: 23563022
[TBL] [Abstract][Full Text] [Related]
17. Cerebral alterations in a MPTP-mouse model of Parkinson's disease--an immunocytochemical study.
Muramatsu Y; Kurosaki R; Watanabe H; Michimata M; Matsubara M; Imai Y; Araki T
J Neural Transm (Vienna); 2003 Oct; 110(10):1129-44. PubMed ID: 14523625
[TBL] [Abstract][Full Text] [Related]
18. MiR-302b-5p enhances the neuroprotective effect of IGF-1 in methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease by regulating inducible nitric-oxide synthase.
Cui X; Li M; He Z; Hu L; Liu J; Yan J; Hua L
Cell Biochem Funct; 2020 Dec; 38(8):1025-1035. PubMed ID: 32474958
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the neuroprotective potential of Mucuna pruriens seed extract with estrogen in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced PD mice model.
Yadav SK; Prakash J; Chouhan S; Westfall S; Verma M; Singh TD; Singh SP
Neurochem Int; 2014 Jan; 65():1-13. PubMed ID: 24333323
[TBL] [Abstract][Full Text] [Related]
20. Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate.
Choi JY; Park CS; Kim DJ; Cho MH; Jin BK; Pie JE; Chung WG
Neurotoxicology; 2002 Sep; 23(3):367-74. PubMed ID: 12387363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
